vs
Side-by-side financial comparison of EverQuote, Inc. (EVER) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.
HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $190.9M, roughly 1.4× EverQuote, Inc.). EverQuote, Inc. runs the higher net margin — 9.8% vs 0.7%, a 9.1% gap on every dollar of revenue. On growth, EverQuote, Inc. posted the faster year-over-year revenue change (14.5% vs -16.5%).
EverQuote, Inc. is an online insurance marketplace founded in 2011 and based in Cambridge, Massachusetts.
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
EVER vs HCM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $190.9M | $270.8M |
| Net Profit | $18.7M | $2.0M |
| Gross Margin | 97.8% | 37.7% |
| Operating Margin | 12.3% | -13.2% |
| Net Margin | 9.8% | 0.7% |
| Revenue YoY | 14.5% | -16.5% |
| Net Profit YoY | 133.7% | -83.6% |
| EPS (diluted) | $0.51 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $190.9M | — | ||
| Q4 25 | $195.3M | $270.8M | ||
| Q3 25 | $173.9M | — | ||
| Q2 25 | $156.6M | $277.7M | ||
| Q1 25 | $166.6M | $324.5M | ||
| Q4 24 | $147.5M | — | ||
| Q3 24 | $144.5M | — | ||
| Q2 24 | $117.1M | $305.7M |
| Q1 26 | $18.7M | — | ||
| Q4 25 | $57.8M | $2.0M | ||
| Q3 25 | $18.9M | — | ||
| Q2 25 | $14.7M | $455.0M | ||
| Q1 25 | $8.0M | $11.9M | ||
| Q4 24 | $12.3M | — | ||
| Q3 24 | $11.6M | — | ||
| Q2 24 | $6.4M | $25.8M |
| Q1 26 | 97.8% | — | ||
| Q4 25 | 97.7% | 37.7% | ||
| Q3 25 | 97.3% | — | ||
| Q2 25 | 96.9% | 0.1% | ||
| Q1 25 | 96.8% | 48.0% | ||
| Q4 24 | 96.3% | — | ||
| Q3 24 | 96.2% | — | ||
| Q2 24 | 95.7% | 41.1% |
| Q1 26 | 12.3% | — | ||
| Q4 25 | 9.5% | -13.2% | ||
| Q3 25 | 10.1% | — | ||
| Q2 25 | 9.0% | -1.3% | ||
| Q1 25 | 4.8% | -5.0% | ||
| Q4 24 | 8.2% | — | ||
| Q3 24 | 8.1% | — | ||
| Q2 24 | 5.4% | -9.0% |
| Q1 26 | 9.8% | — | ||
| Q4 25 | 29.6% | 0.7% | ||
| Q3 25 | 10.8% | — | ||
| Q2 25 | 9.4% | 163.8% | ||
| Q1 25 | 4.8% | 3.7% | ||
| Q4 24 | 8.3% | — | ||
| Q3 24 | 8.0% | — | ||
| Q2 24 | 5.5% | 8.4% |
| Q1 26 | $0.51 | — | ||
| Q4 25 | $1.53 | $0.00 | ||
| Q3 25 | $0.50 | — | ||
| Q2 25 | $0.39 | $0.52 | ||
| Q1 25 | $0.21 | $0.01 | ||
| Q4 24 | $0.35 | — | ||
| Q3 24 | $0.31 | — | ||
| Q2 24 | $0.17 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $178.5M | $1.4B |
| Total DebtLower is stronger | — | $93.2M |
| Stockholders' EquityBook value | $240.9M | $1.2B |
| Total Assets | $324.0M | $1.8B |
| Debt / EquityLower = less leverage | — | 0.08× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $178.5M | — | ||
| Q4 25 | $171.4M | $1.4B | ||
| Q3 25 | $145.8M | — | ||
| Q2 25 | $148.2M | $1.4B | ||
| Q1 25 | $125.0M | $836.1M | ||
| Q4 24 | $102.1M | — | ||
| Q3 24 | $82.8M | — | ||
| Q2 24 | $60.9M | $802.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $93.2M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $93.4M | ||
| Q1 25 | — | $82.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $82.1M |
| Q1 26 | $240.9M | — | ||
| Q4 25 | $238.0M | $1.2B | ||
| Q3 25 | $174.9M | — | ||
| Q2 25 | $170.3M | $1.2B | ||
| Q1 25 | $149.5M | $759.9M | ||
| Q4 24 | $135.4M | — | ||
| Q3 24 | $117.7M | — | ||
| Q2 24 | $100.8M | $740.1M |
| Q1 26 | $324.0M | — | ||
| Q4 25 | $326.9M | $1.8B | ||
| Q3 25 | $256.1M | — | ||
| Q2 25 | $241.4M | $1.8B | ||
| Q1 25 | $232.1M | $1.3B | ||
| Q4 24 | $210.5M | — | ||
| Q3 24 | $180.5M | — | ||
| Q2 24 | $158.0M | $1.3B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.08× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.11× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $29.6M | $8.2M |
| Free Cash FlowOCF − Capex | — | $3.4M |
| FCF MarginFCF / Revenue | — | 1.2% |
| Capex IntensityCapex / Revenue | — | 1.8% |
| Cash ConversionOCF / Net Profit | 1.59× | 4.21× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-96.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $29.6M | — | ||
| Q4 25 | $27.0M | $8.2M | ||
| Q3 25 | $19.8M | — | ||
| Q2 25 | $25.3M | $-72.9M | ||
| Q1 25 | $23.3M | $40.3M | ||
| Q4 24 | $20.1M | — | ||
| Q3 24 | $23.6M | — | ||
| Q2 24 | $12.4M | $-39.8M |
| Q1 26 | — | — | ||
| Q4 25 | $25.8M | $3.4M | ||
| Q3 25 | $18.5M | — | ||
| Q2 25 | $23.8M | $-82.2M | ||
| Q1 25 | $22.2M | $32.5M | ||
| Q4 24 | $19.1M | — | ||
| Q3 24 | $22.1M | — | ||
| Q2 24 | $11.5M | $-49.9M |
| Q1 26 | — | — | ||
| Q4 25 | 13.2% | 1.2% | ||
| Q3 25 | 10.6% | — | ||
| Q2 25 | 15.2% | -29.6% | ||
| Q1 25 | 13.3% | 10.0% | ||
| Q4 24 | 13.0% | — | ||
| Q3 24 | 15.3% | — | ||
| Q2 24 | 9.8% | -16.3% |
| Q1 26 | — | — | ||
| Q4 25 | 0.6% | 1.8% | ||
| Q3 25 | 0.7% | — | ||
| Q2 25 | 0.9% | 3.3% | ||
| Q1 25 | 0.7% | 2.4% | ||
| Q4 24 | 0.7% | — | ||
| Q3 24 | 1.0% | — | ||
| Q2 24 | 0.7% | 3.3% |
| Q1 26 | 1.59× | — | ||
| Q4 25 | 0.47× | 4.21× | ||
| Q3 25 | 1.05× | — | ||
| Q2 25 | 1.72× | -0.16× | ||
| Q1 25 | 2.92× | 3.38× | ||
| Q4 24 | 1.64× | — | ||
| Q3 24 | 2.04× | — | ||
| Q2 24 | 1.93× | -1.54× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EVER
| Automotive | $172.4M | 90% |
| Home and renters | $18.5M | 10% |
HCM
Segment breakdown not available.